免疫チェックポイント阻害剤に関連する神経筋疾患における電気生理学的発見
E Lainez1, A Llauradó2, M Gratacòs-Viñola1
1Department of Clinical Neurophysiology. Vall d'Hebron University Hospital. Passeig de la Vall d'Hebron, 119 Barcelona, Spain.
まとめ
免疫チェックポイント阻害剤 (ICI) 治療は神経筋疾患を引き起こす可能性があります. 骨髄炎はICIに関連する骨髄症/骨髄炎で一般的であり,骨髄病では非骨髄性ポリラジキュロネウロパシーが典型的である. 早期の電気診断は 極めて重要です
科学分野:
- 神経学
- 免疫学
- 腫瘍学
背景:
- 免疫チェックポイント阻害剤 (ICI) は,抗腫瘍免疫を回復する重要ながん治療法ですが,希少で重度の免疫関連の有害事象 (irAEs) を引き起こします.
- 神経学的IRA (n- IRA),特に神経,神経筋結節 (NMJ),および筋肉に影響を与える神経筋疾患は,最も頻繁であり,死亡リスクが最も高い.
- ICIに関連した神経筋肉の合併症の迅速な認識は,患者の管理に不可欠です.
研究 の 目的:
- ICIで治療された患者の神経筋疾患の臨床および電気診断の発見を特徴づける.
- ICI誘発のn-irAEsの神経疾患と神経筋結合/筋肉のフェノタイプを区別する.
主な方法:
- ICI治療後に電気診断評価を受けている,疑われるn- irAEsの38人の患者の遡及分析.
- 2つのフェノタイプに分類される: ir-神経病 (頭蓋骨/外周神経病,根性病) と ir-MG/筋炎 (筋症および/または筋炎).
- モーター/センサリー伝導の研究,F波,針のEMG,単一ファイバーのEMG,繰り返し刺激,および誘発的ポテンシャルを使用しました.
主要な成果:
- この研究では,27人 (71%) がIRMG/ myositis,11人 (29%) がIRNeuropathiesと診断されました.
- 自発的な活動を示す筋炎は,IR-MG/筋炎のグループ内で圧倒的なパターンでした.
- 急性感覚運動脱ミエリン性ポリラジキュロネウロパシーは,神経疾患の中で最も一般的であった.
結論:
- 筋炎は最も頻繁なIR-MG/筋炎パターンであり,脱ミエリン性ポリラジキュロネウロパシーがIR-ニューロパシーの特徴である.
- 神経筋結節機能障害はしばしば筋炎と共存し,電気生理学的評価では見過ごされることがあります.
- 電気診断は,ICIに関連する神経筋肉合併症の早期発見と効果的な管理に不可欠です.
関連する概念動画
Neuromuscular Junction And Blockade
3.6K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.6K
Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
525
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
525
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.1K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.1K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Chemical Synapses
9.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K


